Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016, Article ID 5417565, 23 pages
http://dx.doi.org/10.1155/2016/5417565
Research Article

tPA-MMP-9 Axis Plays a Pivotal Role in Mobilization of Endothelial Progenitor Cells from Bone Marrow to Circulation and Ischemic Region for Angiogenesis

1Institute for Translational Research in Biomedicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan
2Department of Biotechnology, College of Life Science, Kaohsiung Medical University, Kaohsiung 807, Taiwan
3Department of Anesthesiology, Chang Gung Memorial Hospital and Graduate Institute of Clinical Medical Sciences, Chang Gung University, Taoyuan 333, Taiwan
4Department of Emergency Medicine, E-Da Hospital, I-Shou University, Kaohsiung 824, Taiwan
5Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 333, Taiwan
6Center for Shockwave Medicine and Tissue Engineering, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan
7Department of Medical Research, China Medical University Hospital, China Medical University, Taichung 404, Taiwan
8Department of Nursing, Asia University, Taichung 413, Taiwan

Received 2 March 2016; Revised 3 June 2016; Accepted 20 June 2016

Academic Editor: Eva Mezey

Copyright © 2016 Steve Leu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Asahara, H. Masuda, T. Takahashi et al., “Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization,” Circulation Research, vol. 85, no. 3, pp. 221–228, 1999. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Balaji, A. King, T. M. Crombleholme, and S. G. Keswani, “The role of endothelial progenitor cells in postnatal vasculogenesis: implications for therapeutic neovascularization and wound healing,” Advances in Wound Care, vol. 2, no. 6, pp. 283–295, 2013. View at Google Scholar
  3. L.-L. Wang, D. Chen, J. Lee et al., “Mobilization of endogenous bone marrow derived endothelial progenitor cells and therapeutic potential of parathyroid hormone after ischemic stroke in mice,” PLoS ONE, vol. 9, no. 2, Article ID e87284, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. L. Dong, L. Kang, L. Ding et al., “Insulin modulates ischemia-induced endothelial progenitor cell mobilization and neovascularization in diabetic mice,” Microvascular Research, vol. 82, no. 3, pp. 227–236, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. P.-H. Huang, Y.-H. Chen, C.-H. Wang et al., “Matrix metalloproteinase-9 is essential for ischemia-induced neovascularization by modulating bone marrow-derived endothelial progenitor cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 29, no. 8, pp. 1179–1184, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. C.-H. Wang, S. Verma, I.-C. Hsieh et al., “Enalapril increases ischemia-induced endothelial progenitor cell mobilization through manipulation of the CD26 system,” Journal of Molecular and Cellular Cardiology, vol. 41, no. 1, pp. 34–43, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. H.-K. Yip, C.-K. Sun, T.-H. Tsai et al., “Tissue plasminogen activator enhances mobilization of endothelial progenitor cells and angiogenesis in murine limb ischemia,” International Journal of Cardiology, vol. 168, no. 1, pp. 226–236, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Leu, H.-I. Lu, C.-K. Sun et al., “Retention of endothelial progenitor cells in bone marrow in a murine model of endogenous tissue plasminogen activator (tPA) deficiency in response to critical limb ischemia,” International Journal of Cardiology, vol. 170, no. 3, pp. 394–405, 2014. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Ghersi, Q. Zhao, M. Salamone, Y. Yeh, S. Zucker, and W.-T. Chen, “The protease complex consisting of dipeptidyl peptidase IV and seprase plays a role in the migration and invasion of human endothelial cells in collagenous matrices,” Cancer Research, vol. 66, no. 9, pp. 4652–4661, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Imanishi, H. Tsujioka, and T. Akasaka, “Endothelial progenitor cells dysfunction and senescence: contribution to oxidative stress,” Current Cardiology Reviews, vol. 4, no. 4, pp. 275–286, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Heissig, K. Hattori, S. Dias et al., “Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of Kit-ligand,” Cell, vol. 109, no. 5, pp. 625–637, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Hristov and C. Weber, “Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance,” Journal of Cellular and Molecular Medicine, vol. 8, no. 4, pp. 498–508, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Kawai, F. Xue, T. Takahara et al., “Matrix metalloproteinase-9 contributes to the mobilization of bone marrow cells in the injured liver,” Cell Transplantation, vol. 21, no. 2-3, pp. 453–464, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Ould-Yahoui, O. Sbai, K. Baranger et al., “Role of matrix metalloproteinases in migration and neurotrophic properties of nasal olfactory stem and ensheathing cells,” Cell Transplantation, vol. 22, no. 6, pp. 993–1010, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Teraa, R. W. Sprengers, P. E. Westerweel et al., “Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients,” PLoS ONE, vol. 8, no. 1, Article ID e55592, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. Y.-J. Day, L. Huang, M. J. McDuffie et al., “Renal protection from ischemia mediated by A2A adenosine receptors on bone marrow-derived cells,” Journal of Clinical Investigation, vol. 112, no. 6, pp. 883–891, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. R. F. Nicosia, “The aortic ring model of angiogenesis: a quarter century of search and discovery,” Journal of Cellular and Molecular Medicine, vol. 13, no. 10, pp. 4113–4136, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Klein, O. Schmal, and W. K. Aicher, “Matrix metalloproteinases in stem cell mobilization,” Matrix Biology, vol. 44–46, pp. 175–183, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. M. W. Roomi, J. C. Monterrey, T. Kalinovsky, M. Rath, and A. Niedzwiecki, “Distinct patterns of matrix metalloproteinase-2 and -9 expression in normal human cell lines,” Oncology Reports, vol. 21, no. 3, pp. 821–826, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. R. K. Nuttall, C. L. Sampieri, C. J. Pennington, S. E. Gill, G. A. Schultz, and D. R. Edwards, “Expression analysis of the entire MMP and TIMP gene families during mouse tissue development,” FEBS Letters, vol. 563, no. 1–3, pp. 129–134, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. W. Phatharajaree, A. Phrommintikul, and N. Chattipakorn, “Matrix metalloproteinases and myocardial infarction,” Canadian Journal of Cardiology, vol. 23, no. 9, pp. 727–733, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Chaturvedi and L. Kaczmarek, “MMP-9 inhibition: a therapeutic strategy in ischemic stroke,” Molecular Neurobiology, vol. 49, no. 1, pp. 563–573, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Kurihara, R. Shimizu-Hirota, M. Shimoda et al., “Neutrophil-derived matrix metalloproteinase 9 triggers acute aortic dissection,” Circulation, vol. 126, no. 25, pp. 3070–3080, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. C. Johnson, H.-J. Sung, S. M. Lessner, M. E. Fini, and Z. S. Galis, “Matrix metalloproteinase-9 is required for adequate angiogenic revascularization of ischemic tissues: potential role in capillary branching,” Circulation Research, vol. 94, no. 2, pp. 262–268, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. G. Wang, Q. Guo, M. Hossain et al., “Bone marrow-derived cells are the major source of MMP-9 contributing to blood-brain barrier dysfunction and infarct formation after ischemic stroke in mice,” Brain Research, vol. 1294, pp. 183–192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Ramos-DeSimone, E. Hahn-Dantona, J. Sipley, H. Nagase, D. L. French, and J. P. Quigley, “Activation of matrix metalloproteinase-9 (MMP-9) via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion,” The Journal of Biological Chemistry, vol. 274, no. 19, pp. 13066–13076, 1999. View at Publisher · View at Google Scholar · View at Scopus
  27. R. Dreier, S. Wallace, S. Fuchs, P. Bruckner, and S. Grässel, “Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived pro-gelatinase B (pro-MMP-9),” Journal of Cell Science, vol. 114, no. 21, pp. 3813–3822, 2001. View at Google Scholar · View at Scopus
  28. M. Steenport, K. M. F. Khan, B. Du, S. E. Barnhard, A. J. Dannenberg, and D. J. Falcone, “Matrix metalloproteinase (MMP)-1 and MMP-3 induce macrophage MMP-9: evidence for the role of TNF-α and cyclooxygenase-2,” Journal of Immunology, vol. 183, no. 12, pp. 8119–8127, 2009. View at Publisher · View at Google Scholar · View at Scopus